497 related articles for article (PubMed ID: 31764962)
1. Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.
Chan S; Cornelius V; Cro S; Harper JI; Lack G
JAMA Pediatr; 2020 Jan; 174(1):29-37. PubMed ID: 31764962
[TBL] [Abstract][Full Text] [Related]
2. Atopic Dermatitis Anti-IgE Paediatric Trial (ADAPT): the role of anti-IgE in severe paediatric eczema: study protocol for a randomised controlled trial.
Chan S; Cornelius V; Chen T; Radulovic S; Wan M; Jahan R; Lack G
Trials; 2017 Mar; 18(1):136. PubMed ID: 28330497
[TBL] [Abstract][Full Text] [Related]
3. The role of anti-IgE (omalizumab/Xolair) in the management of severe recalcitrant paediatric atopic eczema (ADAPT): statistical analysis plan.
Chen T; Chan S; Lack G; Cro S; Cornelius VR
Trials; 2017 May; 18(1):231. PubMed ID: 28535776
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial.
Paller AS; Flohr C; Cork M; Bewley A; Blauvelt A; Hong HC; Imafuku S; Schuttelaar MLA; Simpson EL; Soong W; Arlert P; Lophaven KW; Kurbasic A; Soldbro L; Vest NS; Wollenberg A
JAMA Dermatol; 2023 Jun; 159(6):596-605. PubMed ID: 37074705
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.
Simpson EL; Paller AS; Siegfried EC; Boguniewicz M; Sher L; Gooderham MJ; Beck LA; Guttman-Yassky E; Pariser D; Blauvelt A; Weisman J; Lockshin B; Hultsch T; Zhang Q; Kamal MA; Davis JD; Akinlade B; Staudinger H; Hamilton JD; Graham NMH; Pirozzi G; Gadkari A; Eckert L; Stahl N; Yancopoulos GD; Ruddy M; Bansal A
JAMA Dermatol; 2020 Jan; 156(1):44-56. PubMed ID: 31693077
[TBL] [Abstract][Full Text] [Related]
6. Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial.
Iyengar SR; Hoyte EG; Loza A; Bonaccorso S; Chiang D; Umetsu DT; Nadeau KC
Int Arch Allergy Immunol; 2013; 162(1):89-93. PubMed ID: 23816920
[TBL] [Abstract][Full Text] [Related]
7. Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial.
Navarro-López V; Ramírez-Boscá A; Ramón-Vidal D; Ruzafa-Costas B; Genovés-Martínez S; Chenoll-Cuadros E; Carrión-Gutiérrez M; Horga de la Parte J; Prieto-Merino D; Codoñer-Cortés FM
JAMA Dermatol; 2018 Jan; 154(1):37-43. PubMed ID: 29117309
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial.
Hon KL; Tsang YC; Lee VW; Pong NH; Ha G; Lee ST; Chow CM; Leung TF
J Dermatolog Treat; 2016; 27(2):156-62. PubMed ID: 26270469
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials.
Paller AS; Ladizinski B; Mendes-Bastos P; Siegfried E; Soong W; Prajapati VH; Lio P; Thyssen JP; Simpson EL; Platt AM; Raymundo EM; Liu J; Calimlim BM; Huang X; Gu Y; Hu X; Yang Y; Su JC; Zheng M; Yamamoto-Hanada K; Teixeira HD; Irvine AD
JAMA Dermatol; 2023 May; 159(5):526-535. PubMed ID: 37043227
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.
Flohr C; Rosala-Hallas A; Jones AP; Beattie P; Baron S; Browne F; Brown SJ; Gach JE; Greenblatt D; Hearn R; Hilger E; Esdaile B; Cork MJ; Howard E; Lovgren ML; August S; Ashoor F; Williamson PR; McPherson T; O'Kane D; Ravenscroft J; Shaw L; Sinha MD; Spowart C; Taams LS; Thomas BR; Wan M; Sach TH; Irvine AD;
Br J Dermatol; 2023 Nov; 189(6):674-684. PubMed ID: 37722926
[TBL] [Abstract][Full Text] [Related]
11. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial.
Chang YS; Lin MH; Lee JH; Lee PL; Dai YS; Chu KH; Sun C; Lin YT; Wang LC; Yu HH; Yang YH; Chen CA; Wan KS; Chiang BL
JAMA Pediatr; 2016 Jan; 170(1):35-42. PubMed ID: 26569624
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study.
Wu YJ; Wu WF; Hung CW; Ku MS; Liao PF; Sun HL; Lu KH; Sheu JN; Lue KH
J Microbiol Immunol Infect; 2017 Oct; 50(5):684-692. PubMed ID: 26733351
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for Patients With Atopic Dermatitis: A Phase 2 Randomized Clinical Trial.
Gooderham MJ; Forman SB; Bissonnette R; Beebe JS; Zhang W; Banfield C; Zhu L; Papacharalambous J; Vincent MS; Peeva E
JAMA Dermatol; 2019 Dec; 155(12):1371-1379. PubMed ID: 31577341
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of systemic therapy for moderate-to-severe atopic dermatitis in children and adolescent patients: a systematic review.
Zheng Y; Ding RL; Bu J
Front Immunol; 2024; 15():1367099. PubMed ID: 38812522
[TBL] [Abstract][Full Text] [Related]
15. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial.
Gerasimov SV; Vasjuta VV; Myhovych OO; Bondarchuk LI
Am J Clin Dermatol; 2010; 11(5):351-61. PubMed ID: 20642296
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Soshiho-tang in atopic dermatitis patients with gastrointestinal disorders: A double-blinded, randomized, and placebo-controlled clinical trial.
Lee JH; Jo EH; Jung JY; Kang SJ; Yang GJ; Shim YH; Park MC
J Ethnopharmacol; 2021 Jun; 274():114006. PubMed ID: 33766759
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases.
García M; Durán-Crane A; Chapman E; García E
Rev Alerg Mex; 2019; 66(3):282-291. PubMed ID: 31606011
[TBL] [Abstract][Full Text] [Related]
18. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Langer SS; Cardili RN; Melo JML; Ferriani MPL; Moreno AS; Dias MM; Bueno-Filho R; Pocente RHC; Roxo-Junior P; Silva J; Valera FCP; Coelho EB; Galvão CES; Carmona F; Aragon DC; Arruda LK
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):539-549.e7. PubMed ID: 34767999
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
